Turn Biotechnologies
InactiveTurn.bio is a biotechnology company developing drugs to reverse aging and age-related diseases. Utilizing a patented mRNA platform technology, ERA, the company is combating the effects of aging on the epigenome. The company’s proprietary mRNA platform technology, ERA and eTurna, a delivery platf...
What it does
"Turn Biotechnologies is a pioneering health company focused on developing innovative drugs to reverse aging and combat age-related diseases. Utilizing their patented mRNA platform technology, ERA, Turn Biotechnologies targets the effects of aging on the epigenome to restore optimal gene expression. Their proprietary mRNA platform technology, ERA, along with the eTurna delivery platform designed for nucleic acid therapeutics, enables the development of tailored therapies for immune-related diseases, cancer, dermatological conditions, ophthalmology, osteoarthritis, and the muscular system. By addressing the root causes of aging at the molecular level, Turn Biotechnologies is at the forefront of revolutionizing healthcare and potentially extending human lifespan."
Next to it in Healthcare and bio · mRNA therapeutics for aging
- Dorian TherapeuticsY Combinator S18
New therapeutics to rejuvenate tissue and treat age-related diseases
- Gerostate AlphaY Combinator S18
Developing novel therapeutics for aging and chronic disease
- AutoPhagyGO Inc.Plug and Play
AutoPhagyGO develops autophagy solutions for the prevention and treatment of neurodegenerative diseases.
- 株式会社FerroptoCurePlug and Play
FerroptoCure specializes in ferroptosis research and the development of effective therapeutic drugs to treat cancer and other diseases.
- 株式会社PURMX TherapeuticsPlug and Play
PURMX is a pharmaceutical company that develops RNA nucleic acid medicine for therapeutic effects on intractable diseases.
- TNAX Biopharma株式会社Plug and Play
TNAX Biopharma is a developer of pharmaceuticals drugs intended to improve the quality of life of patients.
- Helix NanotechnologiesY Combinator W17
Next-generation mRNA platform to solve cancer, COVID and climate.
- Rejuvenation Technologies Inc.Y Combinator S18
mRNA therapeutics to extend healthspan entering clinical trials